SCHEMBL48681

SCHEMBL48681

O=S(=O)(O)CCCN1c2ccccc2Sc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
MAPT P10636 4/20 0.58
MMP13 P45452 2/20 0.58
POLB P06746 2/20 0.58
PIM1 P11309 1/20 0.57
ALOX15 P16050 3/20 0.56
TP53 P04637 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
KDM4E B2RXH2 2/20 0.56
USP2 O75604 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPK1 P28482 1/20 0.56
RAD52 P43351 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
LMNA P02545 3/20 0.55
KDM1A O60341 9/20 0.54
SIGMAR1 Q99720 2/20 0.54
SLC22A1 O15245 1/20 0.54
PRNP P04156 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30115198 1.00 MEN1 (0.58) MEN1KMT2AMAPTMMP13POLB
SCHEMBL30115197 1.00 MEN1 (0.58) MEN1KMT2AMAPTMMP13POLB
SCHEMBL48847 0.98 MEN1 (0.57) MEN1KMT2AMAPTMMP13POLB
SCHEMBL8444747 0.98 MEN1 (0.57) MEN1KMT2AMAPTMMP13POLB
SCHEMBL49291 0.95 PIM1 (0.59) MEN1KMT2AMAPTMMP13POLB
SCHEMBL31384188 0.95 PIM1 (0.59) MEN1KMT2AMAPTMMP13POLB
SCHEMBL3774114 0.94 PIM1 (0.58) MEN1KMT2AMAPTMMP13POLB
SCHEMBL10023985 0.90 MEN1 (0.58) MEN1KMT2AMAPTMMP13POLB
SCHEMBL9102418 0.88 MAPT (0.53) MEN1KMT2AMAPTMMP13POLB
SCHEMBL9102304 0.88 MAPT (0.64) MEN1KMT2AMAPTMMP13POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118858262-B High-sensitivity single-component chemiluminescent substrate, long-acting storage container and application thereof 上海碧云天生物技术股份有限公司 2025-04-22 CN claimed
CN-118858262-A High-sensitivity single-component chemiluminescent substrate, long-acting storage container and application thereof 上海碧云天生物技术股份有限公司 2024-10-29 CN claimed
US-20230417755-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE CYANAGEN S R L (IT) 2023-12-28 US claimed
EP-3686285-B1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE CYANAGEN S R L (IT) 2023-10-11 EP claimed
US-11761964-B2 Ultra-sensitive chemiluminescent substrates for peroxidase CYANAGEN S.R.L. (IT) 2023-09-19 US claimed
CN-115144385-A Chemiluminescent substrate solution with low air interference and high sensitivity 郑州凌思生物科技有限责任公司 2022-10-04 CN claimed
EP-3686285-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE Cyanagen S.r.l. (IT) 2020-07-29 EP claimed
CN-111454718-A Ultrasensitive chemiluminescent substrates for peroxidases 喜雅纳肯有限公司 2020-07-28 CN claimed
US-20200232991-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE CYANAGEN S.R.L. (IT) 2020-07-23 US claimed
EP-2405016-B1 Method for increasing and regulating light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2018-03-21 EP claimed
US-20160291033-A1 HCP ANTISERUM VALIDATION USING A NON -INTERFERING PROTEIN STAIN BIO-RAD LABORATORIES, INC. 2016-10-06 US claimed
EP-1950207-B1 Preparation of high purity phenothiazine n-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity CYANAGEN SRL (IT) 2012-06-20 EP claimed
US-8012705-B2 Nonseparation assay methods BECKMAN COULTER, INC. (US) 2011-09-06 US claimed
US-20110183361-A1 Nonseparation Assay Methods BECKMAN COULTER, INC. (US) 2011-07-28 US claimed
EP-1962095-B1 Method for increasing light emission from a chemiluminescent reaction CYANAGEN SRL (IT) 2011-06-15 EP claimed
US-7855287-B2 Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity CYANAGEN SRL (IT) 2010-12-21 US claimed
EP-1950207-A1 Preparation of high purity phenothiazine n-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity Cyanagen Srl (IT) 2008-07-30 EP claimed
US-20080176251-A1 Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase acitivity CYANAGEN SRL (IT) 2008-07-24 US claimed
CN-118858262-B High-sensitivity single-component chemiluminescent substrate, long-acting storage container and application thereof 上海碧云天生物技术股份有限公司 2025-04-22 CN disclosed
EP-0361470-A2 Method for the chemiluminescence assay of the activity of peroxidase FUJIREBIO INC. (JP) 1990-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176251-A1 Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase acitivity LPO, ARSA, SULT1E1 MEN1 3072/4885KMT2A 3382/4885MAPT 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.